Ulysses Management’s HCA Healthcare HCA Stock Holding History

Ulysses Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50,000	Closed	-$4.85M	–	53
2018 Q1	$4.85M	Buy	+50,000	New	+$4.85M	0.44%	31

Other funds holding HCA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ulysses Management's HCA Position: Q2 2018 in Review

Ulysses Management sold out of HCA Healthcare (HCA) in Q2 2018, closing a stake of 50,000 shares — an estimated $4.85M sold.

Ulysses Management first reported a position in HCA in Q1 2018 and held it in 1 quarter. The position peaked at $4.85M in Q1 2018. 649 funds tracked by Wall St. Rank hold HCA as of Q2 2018.

Ulysses Management reported no remaining HCA Healthcare position as of Q2 2018 after selling out during the quarter.
Ulysses Management sold 50,000 HCA Healthcare shares in Q2 2018, an estimated $4.85M.
Ulysses Management first reported a position in HCA Healthcare in Q1 2018 and held it in 1 quarter.
Ulysses Management's HCA Healthcare position peaked at $4.85M in Q1 2018.
649 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2018.

Based on Ulysses Management's 13F filing for Q2 2018, filed 14 Aug 2018.